Volition Veterinary

The Nu.Q® Vet Cancer Test is an affordable, accessible and easy to use ELISA based screening blood test which can help streamline the diagnostic process for older (7 years and over) or “at risk” dogs (over the age of 4). Now available in 17 countries! Earlier detection of cancer can not only help save lives, it can also improve the quality of life of the dog and more quality time with its owner. Yet, as of today, unlike the human healthcare world where screening for certain cancers is commonplace, there are few cancer screening tests on the veterinary market. Currently, dogs are typically diagnosed when they are unwell or there is a suspicion of cancer. Even then dogs suspected of having cancer are required to undergo a variety of diagnostic tests that may be expensive, time consuming, and painful for the animal. We hope to change this with the intro­duc­tion of the Nu.Q® Vet Cancer Screening Test. A simple, cost effective, easy to use screening blood test to be used with the annual wellness check for older dogs (7 years and older). It may also be a com­ple­men­tary test for younger dogs (4 years and older) of breeds with an increased risk for developing cancer in their lifetimes. This rev­o­lu­tion­ary product has been developed in col­lab­o­ra­tion with Texas A&M University and the results of key studies have been presented at the world’s leading veterinary oncology conferences and published in peer reviewed journals. To find out more, go to www.veterinary.volition.com, email AskNu.QVet@volition.com or speak to your veterinarian. Volition Veterinary Diagnostics Development is a majority-owned subsidiary of VolitionRx Limited (VNRX). For more information go to: www.volition.com